Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Waldeyer

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Herz|April 25, 2022
[Cost-benefit analysis of new lipid-lowering agents]Christopher Blaum, Natalie Arnold, Christoph Waldeyer
Current Opinion in Lipidology|January 26, 2024
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burdenBenjamin Bay, Natalie Arnold, Christoph Waldeyer
Annals of Translational Medicine|October 27, 2018
Beyond conventional secondary prevention in coronary artery disease-what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASUS-TIMI 54? A review on contemporary literatureDaniel Kalbacher, Christoph Waldeyer, Stefan Blankenberg, et al.
Clinical Case Reports|March 26, 2021
Myocardial rupture after percutaneous coronary intervention of an unstable RCA lesion in myocardial infarction and concomitant stroke treated with intravenous fibrinolytic agents: A case reportBenjamin Bay, Christoph Waldeyer, Leander Rimmele, et al.
Progress in Biophysics and Molecular Biology|April 15, 2008
Drugs that interact with cardiac electro-mechanics: old and new targets for treatmentPaulus Kirchhof, Lisa Fortmüller, Christoph Waldeyer, et al.
European Cardiology|June 7, 2021
Inflammation and Cardiovascular Disease: The FutureNatalie Arnold, Katharina Lechner, Christoph Waldeyer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 25, 2021
Completeness of revascularisation in acute coronary syndrome patients with multivessel diseaseValeria Paradies, Christoph Waldeyer, Pietro Leonida Laforgia, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery diseaseChristian Schulte, Luise Pieper, Maike Frye, et al.
Neurosurgical Review|September 12, 2021
Spontaneous spondylodiscitis and endocarditis: interdisciplinary experience from a tertiary institutional case series and proposal of a treatment algorithmLennart Viezens, Marc Dreimann, André Strahl, et al.
Heart and Vessels|April 29, 2022
Establishing a robotic-assisted PCI program: experiences at a large tertiary referral centerFabian J Brunner, Christoph Waldeyer, Elvin Zengin-Sahm, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Herz|April 25, 2022
[Cost-benefit analysis of new lipid-lowering agents]Christopher Blaum, Natalie Arnold, Christoph Waldeyer
Current Opinion in Lipidology|January 26, 2024
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burdenBenjamin Bay, Natalie Arnold, Christoph Waldeyer
Annals of Translational Medicine|October 27, 2018
Beyond conventional secondary prevention in coronary artery disease-what to choose in the era of CANTOS, COMPASS, FOURIER, ODYSSEY and PEGASUS-TIMI 54? A review on contemporary literatureDaniel Kalbacher, Christoph Waldeyer, Stefan Blankenberg, et al.
Clinical Case Reports|March 26, 2021
Myocardial rupture after percutaneous coronary intervention of an unstable RCA lesion in myocardial infarction and concomitant stroke treated with intravenous fibrinolytic agents: A case reportBenjamin Bay, Christoph Waldeyer, Leander Rimmele, et al.
Progress in Biophysics and Molecular Biology|April 15, 2008
Drugs that interact with cardiac electro-mechanics: old and new targets for treatmentPaulus Kirchhof, Lisa Fortmüller, Christoph Waldeyer, et al.
European Cardiology|June 7, 2021
Inflammation and Cardiovascular Disease: The FutureNatalie Arnold, Katharina Lechner, Christoph Waldeyer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 25, 2021
Completeness of revascularisation in acute coronary syndrome patients with multivessel diseaseValeria Paradies, Christoph Waldeyer, Pietro Leonida Laforgia, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery diseaseChristian Schulte, Luise Pieper, Maike Frye, et al.
Neurosurgical Review|September 12, 2021
Spontaneous spondylodiscitis and endocarditis: interdisciplinary experience from a tertiary institutional case series and proposal of a treatment algorithmLennart Viezens, Marc Dreimann, André Strahl, et al.
Heart and Vessels|April 29, 2022
Establishing a robotic-assisted PCI program: experiences at a large tertiary referral centerFabian J Brunner, Christoph Waldeyer, Elvin Zengin-Sahm, et al.
Pageof 6